GlassScriptPhysician profile
Jason Holden
NPI 1295071801
$5,610.25
in general payments reported to CMS, 2019-2025
11 companies · $94.41 in 2025
The $94.41 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,646 · 2022: $920 · 2023: $1,547 · 2024: $403 · 2025: $94.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,084 · Food and Beverage: $961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,084.18 |
| Food and Beverage | $960.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,402.11 | 2021-2023 | Insignia, Mako |
| Smith+Nephew, INC. | $1,515.94 | 2021-2025 | Real Intelligence, Bone Anchors With Arthroscopic Delivery System, Coblation |
| Pacira Pharmaceuticals Incorporated | $1,303.32 | 2023 | Iovera, Zilretta, Exparel |
| Solventum Corporation | $148.17 | 2024 | Prevena |
| Depuy Synthes Sales INC. | $95.90 | 2023-2024 | Orthovisc, Monovisc, Peak |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.74 | 2023 | |
| Amgen INC. | $24.11 | 2023 | Prolia, Evenity |
| Davol INC. | $17.95 | 2023 | |
| Acera Surgical, INC. | $17.17 | 2025 | Restrata Wound Matrix |
| Abbott Laboratories | $16.62 | 2025 | Eterna |
| Boston Scientific Corporation | $15.22 | 2023 | Wavewriter Alpha Prime 16 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Holden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.